Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Volumn 7, Issue 3, 2006, Pages 173-182

  Muddasir Qureshi, M ^a   Hayden, Douglas ^a   Urbinelli, Leo ^a   Ferrante, Kimberly ^a   Newhall, Kristyn ^a   Myers, Daniela ^a   Hilgenberg, Sarah ^a   Smart, Ryan E ^a   Brown, Robert H ^a   Cudkowicz, Merit E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amyotrophic lateral sclerosis; Disease progression; Epidemiology; Motor neuron disease; Risk factors

Indexed keywords

LEAD; PESTICIDE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANAMNESIS; ARTICLE; BULBAR PARALYSIS; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; INJURY; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYMPTOM; UNIVARIATE ANALYSIS;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; COHORT STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33750457344     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820600640596     Document Type: Article

References (90)

1. Kelly, P. and Shapiro, B. (2001) Amyotrophic lateral sclerosis and other motor neuron disorders. In Principles of Neuroepidemiology. (pp. 265-88). Woburn: Butterworth-Heinemann.
2. Kurtzke, J. F. (1991) Risk factors in amyotrophic lateral sclerosis. Adv Neurol, 56, pp. 245-70.
3. Mitchell, J. D. and Davies, R. B. and al-Hamad, A. and Gatrell, A. C. and Batterby, G. (1995) MND risk factors: An epidemiological study in the north-west of England. J Neurol Sci, 129(Suppl.), pp. 61-4.
4. Armon, C. and Kurland, L. and Daube, J. and O'Brien, P. (1991) Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology, 41, pp. 1077-84.
5. Armon, C. (2003) An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology, 22, pp. 217-28.
6. Swash, M.(2000) Clinical features and diagnosis of amyotrophic lateral sclerosis. In Amyotrophic Lateral Sclerosis. (pp. 3-30). London: Martin Dunitz Ltd.
7. Nelson, L. (1996) Epidemiology of ALS. Clin Neurosci, 3, pp. 327-31.
8. Nelson, L. and Matkin, C. and Longstreth, W. and McGuire, V. (2000) Population-based case-control study of amyotrophic lateral sclerosis in western Washington state. II. Diet. Am J Epidemiol, 151, pp. 164-73.
9. Nelson, L. and McGuire, V. and Longstreth, WT. Jr. and Matkin, C. (2000) Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol, 151, pp. 156-63.
10. Armon, C. (2001) Environmental risk factors for amyotrophic lateral sclerosis. Neuroepidemiology, 20, pp. 2-6.
11. Chio, A. (2000) Risk factors in the early diagnosis of ALS: European epidemiological studies. ALS and Other Motor Neuron Disorders, 1(Suppl. 1), pp. S13-8.
12. Brooks, B. (1996) Clinical epidemiology of amyotrophic lateral sclerosis. Neurologic Clinics, 14, pp. 399-420.
13. Appel, V. and Stewart, S. S. and Smith, G. and Appel, S. H. (1987) A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience. Annals of Neurology, 22, pp. 328-33.
14. Brooks, B. and Lewis, D. and Rawling, J.(1994) The natural history of amyotrophic lateral sclerosis. In Motor Neuron Disease. (pp. 131-69). London: Chapman & Hall Medical.
15. Haverkamp, L. J. and Appel, V. and Appel, S. H. (1995) Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain, 118, pp. 707-19.
16. Armon, C. and Graves, M. and Moses, D. and Forte, D. and Sepulveda, L. and Darby, S. and (2000) Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle and Nerve, 23, pp. 874-82.
17. Eisen, A. and Schulzer, M. and MacNeil, M. and Pant, B. and Mak, E. (1993) Duration of amyotrophic lateral sclerosis is age dependent. Muscle and Nerve, 16, pp. 27-32.
18. Cudkowicz, M. and Qureshi, M. and Shefner, J. (2004) Measures and markers in amyotrophic lateral sclerosis. NeuroRx, 1, pp. 284-94.
19. Gordon, P. H. and Miller, R. G. and Moore, D. H. (2004) ALSFRS-R. Amyotrophic Lateral Scler Other Motor Neuron Disord, 5(Suppl 1), pp. 90-3.
20. Stambler, N. and Charatran, M. and Cedarbaum, J. M. (1998) Prognostic indicators of survival in ALS. Neurology, 50, pp. 66-72.
21. Cedarbaum, J. (1996) The amyotrophic lateral sclerosis functional rating scale (ALSFRS). Archives of Neurology, 53, pp. 141-7.
22. Cedarbaum, J. and Stambler, N. and Malta, E. and Fuller, C. and Hilt, D. and Thurmond, B. and (1999) The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci, 169, pp. 13-21.
23. Magnus, T. and Beck, M. and Giess, R. and Puls, I. and Naumann, M. and Toyka, K. V. (2002) Disease progression in amyotrophic lateral sclerosis: Predictors of survival. Muscle Nerve, 25, pp. 709-14.
24. Diggle, P. and Heagerty, P. and Liang, K. and Zeger, S. (2002). In Analysis of longitudinal data. 2nd edn. Oxford: Oxford University Press.
25. McGuire, V. and Longstreth, W. T Jr. and Nelson, L. M. and Koepsell, T. D. and Checkoway, H. and Morgan, M. S. and (1997) Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. American Journal of Epidemiology, 145, pp. 1076-88.
26. Horner, R. and Kamins, K. and Feussner, J. and Hoff-Lindquist, J. and Harati, Y. and Mitsumoto, H. and (2003) Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology, 61, pp. 742-9.
27. Kasarskis, E. and Horner, R. and Gray, K. and Feussner, J. (2002) Amyotrophic lateral sclerosis in military veterans of the Persian Gulf War. Ann Neurol, 52, pp. S96.
28. Kang, H. K. and Bullman, T. A. (1996) Mortality among US Veterans of the Persian Gulf War. N Engl J Med, 335, pp. 1498-1504.
29. Haley, R. (2003) Excess incidence of ALS in young Gulf War veterans. Neurology, 61, pp. 750-6.
30. Weisskopf, M. and O'Reilly, E. and McCullough, M. (2004) Prospective study of military service and risk of amyotrophic lateral sclerosis. In 56th Annual Meeting of the American Academy of Neurology; 2004 April 24-May 1, 2004; San Francisco, California. (pp. S32.002).
31. Weisskopf, M. and O'Reilly, E. and McCullough, M. and Calle, E. and Thun, M. and Cudkowicz, M. and (2005) Prospective study of military service and mortality from ALS. Neurology, 64, pp. 32-7.
32. Qureshi, M. (2005). In. Personal Communication with Alberto Ascherio
33. Ringel, S. and Murphy, J. and Alderson, M. and Bryan, W. and England, J. and Miller, R. and (1993) The natural history of amyotrophic lateral sclerosis. Neurology, 43, pp. 1316-22.
34. Gubbay, S. S. and Kahana, E. and Zilber, N. and Cooper, G. and Leibowitz, Y. (1985) Amyotrophic lateral sclerosis: A study of its presentation and prognosis. J Neurol, 232, pp. 295-300.
35. Mackay, R. (1963) Course and prognosis in amyotrophic lateral sclerosis. Arch Neurol, 8, pp. 17-27.
36. Rosen, A. (1978) Amyotrophic lateral sclerosis. Clinical features and prognosis. Archives of Neurology, 35, pp. 638-42.
37. Norris, F. and Shepherd, R. and Denys, E. and Mukai, E. and Elias, L. and Holden, D. and (1993) Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci, 118, pp. 48-55.
38. Schiffer, D. and Brignolio, F. and Chio, A. and Leone, M. and Rosso, M. G. (1987) A study of prognostic factors in motor neuron disease. Advances in Experimental Medicine & Biology, 209, pp. 255-63.
39. Thijs, V. and Peeters, E. and Theys, P. and Matthijs, G. and Robberecht, W. (2000) Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. Acta Neurol Belg, 100, pp. 84-90.
40. Chio, A. and Mora, G. and Leone, M. (2002) Early symptom progression rate is related to ALS outcome: Prospective population-based study. Neurology, 59, pp. 99-103.
41. Munsat, T. and Andres, P. and Finison, L. and Conlon, T. and Thibodeau, L. (1988) The natural history of motor neuron loss in amyotrophic lateral sclerosis. Neurology, 38, pp. 409-13.
42. Tysnes, O. and Vollset, S. and Aarli, J. (1991) Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand, 83, pp. 280-5.
43. Kasarskis, E. J. and Ehmann, W. D. and Markesbery, W. R. (1993) Trace metals in human neurodegenerative diseases. Progress In Clinical And Biological Research, 380, pp. 299.
44. Felmus, M. T. and Patten, B. M. and Swanke, L. (1976) Antecedent events in amyotrophic lateral sclerosis. Neurology, 26, pp. 167-72.
45. Pierce-Ruhland, R. and Patten, B. M. (1981) Repeat study of antecedent events in motor neuron disease. Ann Clin Res, 13, pp. 102-7.
46. Currier, R. and Haerer, A. (1968) Amyotrophic lateral sclerosis and metallic toxins. Archives of Environmental Health, 17, pp. 712-9.
47. Conradi, S. and Ronnevi, L. and Vesterberg, O. (1976) Abnormal tissue distribution of lead in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 29, pp. 259-65.
48. Kamel, F. and Umbach, D. and Munsat, T. and Shefner, J. and Hu, H. and Sandler, D. (2002) Lead exposure and amyotrophic lateral sclerosis. Epidemiology, 13, pp. 311-9.
49. Mitchell, J. (1987) Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol Clin, 5, pp. 43-60.
50. Mitchell, J. (2000) Amytrophic lateral sclerosis: Toxins and environment. Amyotroph Later Scer Other Motor Neuron Disord, 1, pp. 235-50.
51. Qureshi, M. and Brown, R Jr. and Cudkowicz, M. (2005) Metal and ferritin levels in patients with amyotrophic lateral sclerosis (ALS): A retrospective analysis. Annals Neurology, 58, pp. S39.
52. Khare, S. S. and Ehmann, W. D. and Kasarskis, E. J. and Markesbery, W. R. (1990) Trace element imbalances in amyotrophic lateral sclerosis. Neurotoxicology, 11, pp. 521-32.
53. Strickland, D. and Smith, S. and Dolliff, G. and Goldman, L. and Roelofs, R. (1996) Amyotrophic lateral sclerosis and occupational history. A pilot case-control study. Archives of Neurology, 53, pp. 730-3.
54. Gunnarson, L. and Lindberg, G. and Soderfeldt, B. and Axelson, O. (1991) Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand, 83, pp. 394-8.
55. Chancellor, A. and Slattery, J. and Fraser, H. and Warlow, C. (1993) Risk factors for motor neuron disease: A case-control study based on patients from the Scottish Motor Neuron Disease Register. Journal of Neurology, Neurosurgery and Psychiatry, 56, pp. 1200-6.
56. Kamel, F. and Umbach, D. and Lehman, T. and Park, L. and Munsat, T. and Shefner, J. and (2003) Amyotrophic lateral sclerosis, lead, and genetic susceptibility: Polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environmental Health Perspectives, 111, pp. 1335-9.
57. Savettieri, G. and Salemi, G. and Arcara, A. and Cassata, M. and Castiglione, M. and Fierro, B. (1991) A case-control study of amyotrophic lateral sclerosis. Neuroepidemiology, 10, pp. 242-5.
58. Granieri, E. and Carreras, M. and Tola, R. and Paolino, E. and Tralli, G. and Eleopra, R. and (1988) Motor neuron disease in the province of Ferrara, Italy in 1964-1982. Neurology, 38, pp. 1604-8.
59. Deapen, D. and Henderson, B. (1986) A case-control study of amyotrophic lateral sclerosis. American Journal of Epidemiology, 123, pp. 790-9.
60. Smith, C. A. and Gough, A. C. and Leigh, P. N. and Summers, B. A. and Harding, A. E. and Maraganore, D. M. and (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet, 339, pp. 1375-7.
61. Gough, A. C. and Miles, J. S. and Spurr, N. K. and Moss, J. E. and Gaedigk, A. and Eichelbaum, M. and (1990) Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature, 347, pp. 773-6.
62. Siddons, M. A. and Pickering-Brown, S. M. and Mann, D. M. and Owen, F. and Cooper, P. N. (1996) Debrisoquine hydroxylase gene polymorphism frequencies in patients with amyotrophic lateral sclerosis. Neuroscience Letters, 208, pp. 65-8.
63. Bachus, R. and Neubert, K. and Roots, I. and Prudlo, J. and Brockmoller, J. and Ludolph, A. C. (2003) Polymorphisms of toxifying and detoxifying hepatic enzymes in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry, 74, pp. 1161.
64. Armon, C.(2003) Epidemiology of amyotrophic lateral sclerosis/motor neuron disease. In Motor Neuron Disorders. (pp. 167-206). Philadelphia: Butterworth Heinemann.
65. Chiò, A. and Meineri, P. and Schiffer, D. and Tribolo, A. (1991) Risk factors in motor neuron disease: A case control study. Neuroepidemiology, 10, pp. 174-84.
66. Cruz, D. and Nelson, L. and McGuire, V. and Longstreth, W. (1999) Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: A population based ase-control study. Neuroepidemiology, 18, pp. 101-10.
67. Mandrioli, J. and Faglioni, P. and Merelli, E. and Sola, P. (2003) The epidemiology of ALS in Modena, Italy. Neurology, 60, pp. 683-9.
68. Kurtzke, J. F. and Beebe, G. W. (1980) Epidemiology of amyotrophic lateral sclerosis. 1. A case-control comparison based on ALS deaths. Neurology, 30, pp. 453-62.
69. Kondo, K. and Tsubaki, T. (1981) Case-control studies of motor neuron disease. Arch Neurol, 38, pp. 220-6.
70. Kamel, F. and Umbach, D. and Munsat, T. and Shefner, J. and Sandler, D. (1999) Association of cigarette smoking with ALS. Neuroepidemiology, 18, pp. 194-202.
71. Gallagher, J. and Sanders, M. (1983) Apparent motor neuron disease following the use of pneumatic tools. Ann Neurol, 14, pp. 694-5.
72. Gallagher, J. and Talbert, O. (1991) Motor neuron syndrome after electric shock. Acta Neurol Scand, 83, pp. 79-82.
73. Charles, T. and Swash, M. (2001) Amyotrophic lateral sclerosis: Current understanding. Journal of Neuroscience Nursing, 33, pp. 245-53.
74. Kurland, L. T. and Radhakrishnan, K. and Smith, G. E. and Armon, C. and Nemetz, P. N. (1992) Mechanical trauma as a risk factor in classic amyotrophic lateral sclerosis: Lack of epidemiologic evidence. Journal of Neurological Sciences, 113, pp. 133-43.
75. Strickland, D. and Smith, S. and Dolliff, G. and Goldman, L. and Roelofs, R. (1996) Physical activity, trauma, and ALS: A case-control study. Acta Neurologica Scandinavica, 94, pp. 45-50.
76. Woods, A. (1911) Trauma as a cause of amyotrophic lateral sclerosis. JAMA, 56, pp. 1876-7.
77. Gallagher, J. and Sanders, M. (1987) Trauma and amyotrophic lateral sclerosis: A report of 78 patients. Acta Neurol Scand, 75, pp. 145-50.
78. Waggoner, R. and Lowenberg, K. (1947) Role of trauma in amyotrophic lateral sclerosis. Arch Neurol Psychiatry, 45, pp. 269-303.
79. Juergens, S. and Kurland, L. and Okazaki, H. and Mulder, D. (1980) ALS in Rochester, Minnesota, 1925-1977. Neurology, 30, pp. 463-70.
80. Riggs, J. (1985) Trauma and amyotrophic lateral sclerosis. Arch Neurol, 42, pp. 205.
81. Eisen, A. (1995) Amyotrophic lateral sclerosis is a multifactorial disease. Muscle & Nerve, 18, pp. 741-52.
82. Cleveland, D. and Rothstein, J. (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci, 2, pp. 806-19.
83. Rothstein, J. (1995) Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. In Pathogenesis and therapy of amyotrophic lateral sclerosis. Philadelphia: Lippincott-Raven Publishers.
84. Rothstein, J. D. (1995) Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clinical Neuroscience, 3, pp. 348-59.
85. Bruijn, L. I. and Miller, T. M. and Cleveland, D. W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience, 27, pp. 723-49.
86. Brown, R. H Jr. (1997) Amyotrophic lateral sclerosis. Insights from genetics. Archives of Neurology, 54, pp. 1246-50.
87. Brown, R. H Jr. (1995) Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice. Cell, 80, pp. 687-92.
88. Brown, R. H., Jr. and Robberecht, W. (2001) Amyotrophic lateral sclerosis: Pathogenesis. Seminars in Neurology, 21, pp. 131-9.
89. Wong, P. C. and Rothstein, J. D. and Price, D. L. (1998) The genetic and molecular mechanisms of motor neuron disease. Current Opinion in Neurobiology, 8, pp. 791-9.
90. Siddique, T. and Lalani, I. (2002) Genetic aspects of amyotrophic lateral sclerosis. Neuromuscular Disorders. In (pp. 21-32). Philadelphia: Advances in Neurology, Lippincott Williams and Wilkins.